Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Advance Online Publication
    • Archive
  • About Us
    • About ISASS
    • About the Journal
    • Author Instructions
    • Editorial Board
    • Reviewer Guidelines & Publication Criteria
  • More
    • Advertise
    • Subscribe
    • Alerts
    • Feedback
  • Join Us
  • Reprints & Permissions
  • Sponsored Content
  • Other Publications
    • ijss

User menu

  • My alerts

Search

  • Advanced search
International Journal of Spine Surgery
  • My alerts
International Journal of Spine Surgery

Advanced Search

  • Home
  • Content
    • Current Issue
    • Advance Online Publication
    • Archive
  • About Us
    • About ISASS
    • About the Journal
    • Author Instructions
    • Editorial Board
    • Reviewer Guidelines & Publication Criteria
  • More
    • Advertise
    • Subscribe
    • Alerts
    • Feedback
  • Join Us
  • Reprints & Permissions
  • Sponsored Content
  • Follow ijss on Twitter
  • Visit ijss on Facebook
Research ArticleArticle
Open Access

ISASS Policy Statement – Lumbar Artificial Disc

Jack Zigler and Rolando Garcia
International Journal of Spine Surgery January 2015, 9 7; DOI: https://doi.org/10.14444/2007
Jack Zigler
1Texas Back Institute, Plano, TX
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rolando Garcia
2Orthopedic Care Center, Aventura, FL
MD, MPH, FAAOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1

    Inclusion and Exclusion Criteria for ProDisc-L (from the FDA SS&E labelling document).

    InclusionExclusion
    • Degenerative Disc Disease (DDD) in one vertebral level between L3 and S1. Diagnosis of DDD requires back and/or leg (radicular pain); and radiographic confirmation of any 1 of the following by CT, MRI, discography, plain film, myelography and/or flexion/extension films:

      • Instability (≥3mm translation or ≥5° angulation;

      • Decreased disc height >2mm;

      • Scarring/thickening of annulus fibrosis;

      • Herniated nucleus pulposus; or

      • Vacuum phenomenon

    • Age between 18 and 60 years

    • Failed at least 6 months of conservative treatment

    • Oswestry Low Back Pain Disability Questionnaire score of at least 20/50 (40%) (Interpreted as moderate/severe disability)

    • Psychosocially, mentally and physically able to fully comply with this protocol including adhering to follow-up schedule and

    • Signed inform consent

    • No more than 1 vertebral level may have DDD, and all diseased levels must be treated

    • Patients with involved vertebral endplates dimensionally smaller than 34.5 mm in the medial-lateral and/or 27 mm in the anterior-posterior directions

    • Known allergy to titanium, polyethylene, cobalt, chromium or molybdenum

    • Prior fusion surgery at any vertebral level

    • Clinically compromised vertebral bodies at the affected level due to current or past trauma

    • Radiographic confirmation of facet joint disease or degeneration

    • Lytic spondylolisthesis or spinal stenosis

    • Degenerative spondylolisthesis of grade > 1

    • Back or leg pain of unknown etiology

    • Osteopenia or osteoporosis: A screening questionnaire for osteoporosis, SCORE (Simple Calculated Osteoporosis Risk Estimation), will be used to screen patients to determine if a DEXA scan is required. If DEXA is required, exclusion will be defined as a DEXA bone density measured T score < -2.5.

    • Paget's disease, osteomalacia or anything other metabolic bone disease (excluding osteoporosis which is addressed above)

    • Morbid obesity defined as a body mass index > 40 or a weight more than 100 lbs. over ideal body weight

    • Pregnant or interested in becoming pregnant in the next 3 years

    • Active infection – systemic or local

    • Taking medication or any drug known to potentially interfere with bone/soft tissue healing (e.g., steroids)

    • Rheumatoid arthritis or other autoimmune disease

    • Systemic disease including AIDS, HIV, Hepatitis

    • Active malignancy: A patient with a history of any invasive malignancy (except non-melanoma skin cancer) unless he/she has been treated with curative intent and there has been no clinical signs or symptoms of the malignancy for at least 5 years

    • View popup
    Table 2

    Indications and Contraindications for ProDisc-L.

    Indications for UseContraindications
    The ProDisc-L Total Disc Replacement is indicated for spinal arthroplasty in skeletally mature patients with degenerative disc disease (DDD) at one level from L3-S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These DDD patients should have no more than Grade 1 spondylolisthesis at the involved level. Patients receiving the ProDisc-L Total Disc Replacement should have failed at least six months of conservative treatment prior to implantation of the ProDisc-L Total Disc Replacement.The ProDisc-L Total Disc Replacement should not be implanted in patients with the following conditions:
    • Active systemic infection or infection localized to the site of implantation

    • Osteopenia or osteoporosis defined as DEXA bone density measured T-score < -1.0

    • Bony lumbar spinal stenosis

    • Allergy or sensitivity to implant materials (cobalt, chromium, molybdenum, polyethylene, titanium)

    • Isolated radicular compression syndromes, especially due to disc herniation

    • Pars defect

    • Involved vertebral endplate that is dimensionally smaller than 34.5 mm in the medial-lateral and/or 27mm in the anterior-posterior directions

    • Clinically compromised vertebral bodies at the affected level due to current or past trauma

    • Lytic spondylolisthesis or degenerative spondylolisthesis of grade > 1

PreviousNext
Back to top

In this issue

International Journal of Spine Surgery
Vol. 9
1 Jan 2015
  • Table of Contents
  • Index by author

Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on International Journal of Spine Surgery.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
ISASS Policy Statement – Lumbar Artificial Disc
(Your Name) has sent you a message from International Journal of Spine Surgery
(Your Name) thought you would like to see the International Journal of Spine Surgery web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
ISASS Policy Statement – Lumbar Artificial Disc
Jack Zigler, Rolando Garcia
International Journal of Spine Surgery Jan 2015, 9 7; DOI: 10.14444/2007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
ISASS Policy Statement – Lumbar Artificial Disc
Jack Zigler, Rolando Garcia
International Journal of Spine Surgery Jan 2015, 9 7; DOI: 10.14444/2007
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Rationale
    • Conclusions
    • Disclosures
    • References
    • Additional Literature on Lumbar Total Disc Replacement
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • The Future of Arthroplasty in the Spine
  • We Need to Talk about Lumbar Total Disc Replacement
  • Google Scholar

More in this TOC Section

  • Accuracy of Pedicle Screw Placement Using the ExcelsiusGPS Robotic Navigation Platform: An Analysis of 728 Screws
  • Management of Spinal Langerhans Cell Histiocytosis in Children: A Systematic Review
  • Meta-Analysis Investigating Optimal Timing of Chemoprophylaxis for Venous Thromboembolism in Operatively Managed Blunt Spinal Injuries
Show more Article

Similar Articles

Keywords

  • lumbar artificial disc
  • lumbar arthroplasty
  • lumbar disc replacement

Content

  • Current Issue
  • Latest Content
  • Archive

More Information

  • About IJSS
  • About ISASS
  • Privacy Policy

More

  • Subscribe
  • Alerts
  • Feedback

Other Services

  • Author Instructions
  • Join ISASS
  • Reprints & Permissions

© 2025 International Journal of Spine Surgery

International Journal of Spine Surgery Online ISSN: 2211-4599

Powered by HighWire